Researchers from Helmholtz Munich and international collaborators have revealed that gut bacteria can actively influence human immune responses by injecting proteins directly into our cells. This groundbreaking study uncovers a previously unknown mechanism of communication between commensal bacteria and human cells, challenging the long-held view that these microbes are merely passive residents of the gut.

The implications of this discovery are significant for the longevity and healthspan fields. By systematically mapping over a thousand interactions between bacterial effector proteins and human proteins, the researchers demonstrated that these interactions predominantly target immune regulation and metabolic pathways. Notably, the presence of genes associated with these effector proteins was found to be more common in the gut microbiomes of individuals with Crohn’s disease, suggesting a direct link to chronic inflammation and autoimmune conditions.

This research not only enhances our understanding of the microbiome’s role in health and disease but also opens avenues for targeted therapeutic strategies. Future investigations into specific bacterial proteins could lead to novel interventions for preventing and treating inflammatory diseases, ultimately contributing to improved healthspan outcomes.

Source: sciencedaily.com